Identification of an Attenuated Substrain of Francisella tularensis SCHU S4 by Phenotypic and Genotypic Analyses
- Univ. of New Mexico Health Sciences Center, Albuquerque, NM (United States)
- Univ. of Pittsburgh, PA (United States)
- Lovelace Respiratory Research Inst., Albuquerque, NM (United States)
- Argonne National Lab. (ANL), Argonne, IL (United States)
- Argonne National Lab. (ANL), Argonne, IL (United States); Univ. of Chicago, IL (United States)
- Univ. of Botswana, Gaborone (Botswana)
- Univ. of Maryland School of Medicine, Baltimore, MD (United States)
Pneumonic tularemia is a highly debilitating and potentially fatal disease caused by inhalation of Francisella tularensis. Most of our current understanding of its pathogenesis is based on the highly virulent F. tularensis subsp. tularensis strain SCHU S4. However, multiple sources of SCHU S4 have been maintained and propagated independently over the years, potentially generating genetic variants with altered virulence. In this study, the virulence of four SCHU S4 stocks (NR-10492, NR-28534, NR-643 from BEI Resources and FTS-635 from Battelle Memorial Institute) along with another virulent subsp. tularensis strain, MA00-2987, were assessed in parallel. In the Fischer 344 rat model of pneumonic tularemia, NR-643 and FTS-635 were found to be highly attenuated compared to NR-10492, NR-28534, and MA00-2987. In the NZW rabbit model of pneumonic tularemia, NR-643 caused morbidity but not mortality even at a dose equivalent to 500x the LD50 for NR-10492. Genetic analyses revealed that NR-10492 and NR-28534 were identical to each other, and nearly identical to the reference SCHU S4 sequence. NR-643 and FTS-635 were identical to each other but were found to have nine regions of difference in the genomic sequence when compared to the published reference SCHU S4 sequence. Given the genetic differences and decreased virulence, NR-643/FTS-635 should be clearly designated as a separate SCHU S4 substrain and no longer utilized in efficacy studies to evaluate potential vaccines and therapeutics against tularemia. View Full-Text
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States)
- Sponsoring Organization:
- National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Department of Health and Human Services
- Grant/Contract Number:
- AC02-06CH11357; HHSN272201000037I-HHSN27200001; HHSN272201400027C; U01 AI077909-01; 1 R01 AI123129-01
- OSTI ID:
- 1787299
- Journal Information:
- Pathogens, Vol. 10, Issue 6; ISSN 2076-0817
- Publisher:
- MDPICopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Rapid Countermeasure Discovery against Francisella tularensis Based on a Metabolic Network Reconstruction
Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies